Cargando…

Effects of an SGLT Inhibitor on the Production, Toxicity, and Elimination of Gut-Derived Uremic Toxins: A Call for Additional Evidence

Sodium–glucose cotransporter (SGLT) inhibitors are a class of oral hypoglycemic agents, which, in recent years, have been shown to improve renal and cardiovascular outcomes in patients with diabetic and non-diabetic chronic kidney disease. There remains considerable debate regarding the potential gl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Evenepoel, Pieter, Meijers, Bjorn, Masereeuw, Rosalinde, Lowenstein, Jerome
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8954461/ https://www.ncbi.nlm.nih.gov/pubmed/35324707 http://dx.doi.org/10.3390/toxins14030210

Ejemplares similares

The Evolving View of Uremic Toxicity
por: Meijers, Bjorn, et al.
Publicado: (2022)

Food-Derived Uremic Toxins in Chronic Kidney Disease
por: Lauriola, Mara, et al.
Publicado: (2023)

Protein-Bound Uremic Toxins in Senescence and Kidney Fibrosis
por: Yang, Yi, et al.
Publicado: (2023)

Selective Transport of Protein-Bound Uremic Toxins in Erythrocytes
por: Deltombe, Olivier, et al.
Publicado: (2019)

The Uremic Toxin Indoxyl Sulfate Accelerates Senescence in Kidney Proximal Tubule Cells
por: Yang, Yi, et al.
Publicado: (2023)

Uremic Toxins in Organ Crosstalk
por: Lowenstein, Jerome, et al.
Publicado: (2021)

Derivation and elimination of uremic toxins from kidney-gut axis
por: Xu, Ying, et al.
Publicado: (2023)

Uremic Toxins and Vascular Calcification–Missing the Forest for All the Trees
por: Rapp, Nikolas, et al.
Publicado: (2020)

Bioengineered Kidney Tubules Efficiently Clear Uremic Toxins in Experimental Dialysis Conditions
por: Faria, João, et al.
Publicado: (2023)

Sevelamer Use in End-Stage Kidney Disease (ESKD) Patients Associates with Poor Vitamin K Status and High Levels of Gut-Derived Uremic Toxins: A Drug–Bug Interaction?
por: Dai, Lu, et al.
Publicado: (2020)

Effect of Vancomycin on the Gut Microbiome and Plasma Concentrations of Gut-Derived Uremic Solutes
por: Nazzal, Lama, et al.
Publicado: (2021)

Drugs Commonly Applied to Kidney Patients May Compromise Renal Tubular Uremic Toxins Excretion
por: Mihaila, Silvia M., et al.
Publicado: (2020)

Uremic Toxins Induce ET-1 Release by Human Proximal Tubule Cells, which Regulates Organic Cation Uptake Time-Dependently
por: Schophuizen, Carolien M. S., et al.
Publicado: (2015)

The Dual Roles of Protein-Bound Solutes as Toxins and Signaling Molecules in Uremia
por: Masereeuw, Rosalinde
Publicado: (2022)

Animal Models for Studying Protein-Bound Uremic Toxin Removal—A Systematic Review
por: Ahmed, Sabbir, et al.
Publicado: (2023)

The uremic retention solute p-cresyl sulfate alters NO signal transduction by alteration of the soluble guanylate cyclase redox state
por: Meijers, Björn KI, et al.
Publicado: (2009)

Uremic Toxin Clearance and Cardiovascular Toxicities
por: Mair, Robert D., et al.
Publicado: (2018)

Gut Microbiota Dynamics and Uremic Toxins
por: Mishima, Eikan, et al.
Publicado: (2022)

Protein-Bound Uremic Toxins Induce Reactive Oxygen Species-Dependent and Inflammasome-Mediated IL-1β Production in Kidney Proximal Tubule Cells
por: Mihajlovic, Milos, et al.
Publicado: (2021)

Lipid Profile Is Negatively Associated with Uremic Toxins in Patients with Kidney Failure—A Tri-National Cohort
por: Hobson, Sam, et al.
Publicado: (2022)

The Role of Gut Dysbiosis in the Bone–Vascular Axis in Chronic Kidney Disease
por: Evenepoel, Pieter, et al.
Publicado: (2020)

Gut-Derived Protein-Bound Uremic Toxins
por: Graboski, Amanda L., et al.
Publicado: (2020)

The Impact of CKD on Uremic Toxins and Gut Microbiota
por: Rysz, Jacek, et al.
Publicado: (2021)

Gut Microbiota as a Source of Uremic Toxins
por: Popkov, Vasily A., et al.
Publicado: (2022)

Gut Microbiota and Cardiovascular Uremic Toxicities
por: Velasquez, Manuel T., et al.
Publicado: (2018)

Uremic Toxins Inhibit Transport by Breast Cancer Resistance Protein and Multidrug Resistance Protein 4 at Clinically Relevant Concentrations
por: Mutsaers, Henricus A. M., et al.
Publicado: (2011)

Intestinal Chelators, Sorbants, and Gut-Derived Uremic Toxins
por: Laville, Solène M., et al.
Publicado: (2021)

The effect of isohydric hemodialysis on the binding and removal of uremic retention solutes
por: Etinger, Aleksey, et al.
Publicado: (2018)

Bioengineered kidney tubules efficiently excrete uremic toxins
por: Jansen, J., et al.
Publicado: (2016)

Introduction to the Toxins Special Issue on “Novel Issues in Uremic Toxicity”
por: Vanholder, Raymond
Publicado: (2018)

Correction: The effect of isohydric hemodialysis on the binding and removal of uremic retention solutes
por: Etinger, Aleksey, et al.
Publicado: (2018)

The Influence of Dietary Protein Intake on Mammalian Tryptophan and Phenolic Metabolites
por: Poesen, Ruben, et al.
Publicado: (2015)

The Influence of Prebiotic Arabinoxylan Oligosaccharides on Microbiota Derived Uremic Retention Solutes in Patients with Chronic Kidney Disease: A Randomized Controlled Trial
por: Poesen, Ruben, et al.
Publicado: (2016)

Elimination of Endogenous Toxin, Creatinine from Blood Plasma Depends on Albumin Conformation: Site Specific Uremic Toxicity & Impaired Drug Binding
por: Varshney, Ankita, et al.
Publicado: (2011)

Zebrafish as a Model of Cardiac Pathology and Toxicity: Spotlight on Uremic Toxins
por: Coppola, Annapaola, et al.
Publicado: (2023)

Contribution of Gut Microbiota-Derived Uremic Toxins to the Cardiovascular System Mineralization
por: Filipska, Iwona, et al.
Publicado: (2021)

Protein-Bound Uremic Toxins in Hemodialysis Patients Relate to Residual Kidney Function, Are Not Influenced by Convective Transport, and Do Not Relate to Outcome
por: van Gelder, Maaike K., et al.
Publicado: (2020)

Uremic Toxins and Vascular Dysfunction
por: Six, Isabelle, et al.
Publicado: (2020)

Uremic Solutes in Chronic Kidney Disease and Their Role in Progression
por: van den Brand, Jan A. J. G., et al.
Publicado: (2016)

Functional Genomic Analysis Identifies Indoxyl Sulfate as a Major, Poorly Dialyzable Uremic Toxin in End-Stage Renal Disease
por: Jhawar, Sachin, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_tqg5vqsni1hpk8bgdl577ktrsn